CCM
GSK icon

CrestPoint Capital Management’s GSK GSK Stock Holding History

CrestPoint Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-17,280
Closed -$923K – 233
2014
Q4 		$923K Sell
17,280
-960
-5% -$53.7K 0.5% 72
2014
Q3 		$1.05M Sell
18,240
-7,776
-30% -$477K 0.63% 59
2014
Q2 		$1.74M Sell
26,016
-2,320
-8% -$157K 1.01% 17
2014
Q1 		$1.89M Sell
28,336
-792
-3% -$53.5K 1.18% 14
2013
Q4 		$1.94M Buy
+29,128
New +$1.89M 1.29% 8

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CrestPoint Capital Management's GSK Position: Q1 2015 in Review

CrestPoint Capital Management sold out of GSK (GSK) in Q1 2015, closing a stake of 17,280 shares — an estimated $923K sold.

CrestPoint Capital Management first reported a position in GSK in Q4 2013 and held it in 5 quarters. The position peaked at $1.94M in Q4 2013. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • CrestPoint Capital Management reported no remaining GSK position as of Q1 2015 after selling out during the quarter.
  • CrestPoint Capital Management sold 17,280 GSK shares in Q1 2015, an estimated $923K.
  • CrestPoint Capital Management first reported a position in GSK in Q4 2013 and held it in 5 quarters.
  • CrestPoint Capital Management's GSK position peaked at $1.94M in Q4 2013.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on CrestPoint Capital Management's 13F filing for Q1 2015, filed 14 Apr 2015.